FDA acts against five medical practitioners

Nashik: The Food and Drugs’ Administration (FDA), Nashik division, has started taking action against unauthorized medical practitioners, who are carrying and prescribing allopathic medicine to the patients coming to them without having the requisite knowledge.
Last month, five such medical practitioners were identified in the district. While three are from Nandgaon taluka, one is from Nashik taluka and another is from Satpur area in Nashik city.

Joint director of FDA (drugs), Nashik, Madhuri Pawar said, “The report about the concerned medical practitioners has been sent to the district-level committee which will decide the future course of action.”

“These medical practitioners are unqualified but provide allopathy treatment to patients coming to them. Such people stock large quantities of allopathy medicines and treat patients, including giving injections. This is like playing with the lives of the patients. Hence, action was taken after receiving secret information from a civilian,” said Pawar.

Among these doctors, one had done a correspondence diploma course in herbal medicine and others had a diploma in electropathy alternative medicine and naturopathy. None of them had. the requisite qualifications of treating patients with allopathy medicines.

Pawar said the drugs department had also conducted a special drive in December under the Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954, in which raids were conducted at three places and medicine worth over Rs 12 lakh was seized.

  • Related Posts

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

    Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

    Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore